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for 2014. This prevalence is increasing compared to that 
described in France in 2012 (14%). We found 35 A→G 
substitutions at position 2058 or 2059, two A2062T mu-
tations and one A2059C mutation (Table) (1,9). Notably, 
in patients 15 and 33, who were infected with strains with 
macrolide resistance–associated mutations, M. genitalium 
infection was unsuccessfully treated with azithromycin, 
with treatment failures after azithromycin (1 g) and extend-
ed azithromycin (1.5 g for 5 d), but moxifloxacin treatment 
was effective. Patient 15 had been treated 1 year earlier 
with azithromycin (1 g) for nongonococcal urethritis.
Among the 168 patients whose isolates were exam-
ined for the 23S rRNA, gyrA, and parC genes, strains 
from 2 patients (patients 3 and 6) had both macrolide- 
and fluoroquinolone-associated mutations (1.2%; 95% CI 
0.33%–4.24%). Both patients received azithromycin (1 
g), and patient 6 received additional azithromycin (1.5 g) 
after failure of azithromycin (1 g). Patient 6 experienced 
azithromycin failure again after the extended regimen. M. 
genitalium multidrug resistance is described in France at 
a prevalence of 1.2%, lower than prevalence described in 
Australia (7.5%) (7) and Japan (30.8%) (10).
In conclusion, M. genitalium fluoroquinolone resistance 
is emerging in France, with a prevalence of 6% in 2013–
2014. Further, macrolide resistance also increased during 
this period, to a rate of 17.2%. Patients infected with M. gen-
italium strains containing both macrolide and fluoroquino-
lone resistance mutations associated with therapeutic failure 
raise concerns about untreatable M. genitalium infections.
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To the Editor: Plasmid-mediated, colistin-resistance 
mechanism gene mcr-1 was first identified in Escherichia 
coli isolates from food, food animals, and human patients 
in November 2015 (1). Reports on detection of mcr-1 
in Enterobacteriaceae from humans and food animals 
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soon followed from ≈12 countries (2–5). Here we report 
detection of mcr-1 in colistin-resistant E. coli isolated 
from companion animals and the possible transmission 
of mcr-1–harboring E. coli between companion animals 
and a person.
Three mcr-1–harboring E. coli clinical isolates were 
identified from specimens of 3 patients admitted to a 
urology ward of a hospital in Guangzhou, China. E. coli 
isolate EC07 was identified in the urine of a 50-year-old 
male patient with glomerulonephritis in October 2015. 
Isolate EC08 was cultured from the urine of a 48-year-
old male patient with prostatitis in December 2015. Iso-
late EC09 was identified in the blood of an 80-year-old 
male patient with bladder cancer 3 weeks after EC08 
was identified.
Review of medical records identified the patient carry-
ing E. coli isolate EC07 as a worker at a pet shop. In light 
of this finding, we collected a total of 53 fecal samples from 
39 dogs and 14 cats in the pet shop where the man worked. 
We isolated and identified colonies consistent with E. coli 
from fecal samples on MacConkey agar plates (Thermo 
Fisher, Beijing, China) and API 20E system (bioMérieux, 
Durham, NC, USA). We prepared crude DNA samples of 
isolates for PCR testing by boiling cells in water. Among 
them, 6 were positive for mcr-1 by PCR and sequencing (4 
from dogs and 2 from cats). All 6 isolates were resistant to 
colistin, polymyxin B, cephalosporin, gentamicin, and cip-
rofloxacin by using the agar dilution method, in accordance 
with the European Committee on Antimicrobial Suscepti-
bility Testing (http://www.eucast.org) for colistin and poly-
myxin B and Clinical and Laboratory Standards Institute 
guidelines (http://www.clsi.org) for the other antimicrobial 
drugs. We identified various resistance genes accounting 
for the multidrug resistance in these 9 mcr-1–positive iso-
lates (6,7) (Table). We noted that E. coli isolate EC09 was 
also resistant to carbapenems and positive for blaIMP-4. We 
observed co-production of mcr-1 and IMP-type metallo-β-
lactamase in E. coli.
We subjected all isolates to multilocus sequence 
typing, in accordance with the protocol described at 
http://mlst.warwick.ac.uk/mlst/dbs/Ecoli, and pulsed-
field gel electrophoresis as described previously (8–10).
We identified 5 mcr-1–positive isolates from 4 dogs 
(PET02–04 and PET06) and isolate EC07 as sequence 
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Table. Characteristics of 9 mcr-1–positive Escherichia coli isolates from companion animals and human patients, Guangzhou, China* 
Characteristic 
Isolate 
PET01 PET02 PET03 PET04 PET05 PET06 EC07 EC08 EC09 
Isolation date 2016 Jan 1 2016 Jan 1 2016 Jan 2 2016 Jan 2 2016 Jan 2 2016 Jan 
4 
2015 Oct 
10 
2015 Nov 
2 
2015 Nov 
21 
Specimen 
source 
Cat Dog Dog Dog Cat Dog Human Human Human 
Specimen type Feces Feces Feces Feces Feces Feces Urine Urine Blood 
Phylogenetic 
group 
B2 D D D B2 D D B1 B1 
ST† ST93 ST354 ST354 ST354 New ST354 ST354 ST156 ST156 
PFGE type IV I I I V I I II III 
Resistance 
genes 
mcr-1, 
blaTEM-1, 
qepA 
mcr-1, 
blaTEM-1, 
blaCTX-M-15, 
fosA3, 
aac(6′)-Ib-
cr 
mcr-1, 
blaTEM-1, 
blaCTX-M-15, 
fosA3, 
aac(6′)-Ib-
cr 
mcr-1, 
blaTEM-1, 
blaCTX-M-15, 
fosA3, 
aac(6′)-Ib-
cr 
mcr-1, 
blaTEM-1, 
blaSHV-12, 
blaCTX-M-15, 
fosA3, rmtB, 
qnrS, 
aac(6′)-Ib-cr 
mcr-1, 
blaTEM-1, 
blaCTX-M-15, 
fosA3, 
aac(6′)-Ib-
cr 
mcr-1, 
blaTEM-1, 
blaCTX-M-15, 
fosA3, 
aac(6′)-Ib-
cr 
mcr-1, 
blaTEM-1, 
blaCTX-M-55, 
fosA3, 
rmtB, 
qepA1 
mcr-1, 
blaIMP-4, 
blaTEM-1, 
blaCTX-M-55, 
fosA3, 
rmtB, 
qepA1 
MIC, g/mL          
 Colistin 16 8 8 16 16 8 8 8 64 
 Polymyxin B 16 16 16 32 16 16 8 8 64 
 Ampicillin >256 >256 >256 >256 >256 >256 >256 >256 >256 
 AMX/CLV 16 32 32 32 256 16 32 16 16 
 Cefotaxime 64 >256 256 >256 256 >256 256 256 >256 
 Ceftazidime 16 256 128 256 64 256 128 32 >256 
 Cefepime 8 256 128 256 16 256 64 64 >256 
 Gentamicin 128 >256 >256 >256 256 >256 >256 >256 >256 
 Amikacin 4 >256 >256 >256 >256 >256 >256 >256 >256 
 Ertapenem <0.25 1 0.5 0.25 <0.25 1 0.5 <0.25 >16 
 Imipenem <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 >16 
 Meropenem <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 >16 
 Fosfomycin 32 >512 >512 >512 >512 >512 >512 >512 >512 
 Tigecycline <2 <2 <2 <2 <2 <2 <2 <2 4 
 Nitrofurantoin <16 32 32 32 128 32 64 64 32 
 Ciprofloxacin 256 128 128 128 64 128 128 256 256 
*AMX/CLV, amoxicillin clavulanic acid; PFGE, pulsed-field gel electrophoresis; ST, sequence type. 
†By multilocus sequence typing. 
 
type (ST) 354. Isolates PET01 and PET05, identified 
from cats, belonged to ST93 and a new ST strain, respec-
tively. Isolates EC08 and EC09, from the patients who 
shared the same hospital room with the pet shop worker, 
were ST156 (Table). Results of pulsed-field gel electro-
phoresis were consistent with multilocus sequence typ-
ing results and showed that isolates consisted of 5 types 
(types I to V; online Technical Appendix, http://wwwnc.
cdc.gov/EID/article/22/9/16-0464-Techapp1.pdf). Iso-
late EC07 was clonally related to 4 E. coli strains from 
dogs, according criteria described by Tenover et al. (10), 
suggesting possible transmission of mcr-1–harboring E. 
coli between dogs and the patient. Colistin resistance 
was successfully transferred to E. coli C600 through 
conjugation in all isolates, suggesting that mcr-1 was lo-
cated on transferable plasmids.
These findings suggest that mcr-1–producing E. coli 
can colonize companion animals and be transferred be-
tween companion animals and humans. The findings also 
suggest that, in addition to food animals and humans, com-
panion animals can serve as a reservoir of colistin-resistant 
E. coli, adding another layer of complexity to the rapidly 
evolving epidemiology of plasmid-mediated colistin resis-
tance in the community.
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To the Editor: Acetobacter indonesiensis, first de-
scribed in 2000 (1), belongs to the group of acetic acid 
bacteria (AAB), which includes the genera Acetobacter, 
Gluconobacter, Asaia, Granulibacter, and others in the 
family Acetobacteriaceae. AAB are of great industrial in-
terest for use in vinegar fermentation processes because 
they oxidize alcohols or sugars incompletely, which leads 
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